UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Global Medical REIT Inc. (NYSE:GMRE - Free Report) by 158.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 120,614 shares of the company's stock after buying an additional 73,965 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.18% of Global Medical REIT worth $1,195,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Gordian Capital Singapore Pte Ltd acquired a new stake in Global Medical REIT during the second quarter worth approximately $100,000. Intech Investment Management LLC acquired a new stake in shares of Global Medical REIT during the third quarter worth $150,000. Versor Investments LP acquired a new stake in shares of Global Medical REIT during the third quarter worth $189,000. M&G PLC acquired a new position in Global Medical REIT in the third quarter valued at $193,000. Finally, First Trust Direct Indexing L.P. increased its stake in Global Medical REIT by 25.6% in the third quarter. First Trust Direct Indexing L.P. now owns 20,432 shares of the company's stock valued at $202,000 after purchasing an additional 4,164 shares during the last quarter. Institutional investors and hedge funds own 57.52% of the company's stock.
Analyst Ratings Changes
Several analysts have commented on the company. Berenberg Bank assumed coverage on Global Medical REIT in a report on Friday, October 18th. They issued a "buy" rating and a $11.75 price target for the company. Alliance Global Partners assumed coverage on shares of Global Medical REIT in a research report on Thursday, September 19th. They issued a "buy" rating and a $12.00 target price on the stock.
Check Out Our Latest Analysis on GMRE
Global Medical REIT Trading Down 4.0 %
Shares of Global Medical REIT stock traded down $0.34 during trading hours on Wednesday, reaching $8.12. The stock had a trading volume of 579,459 shares, compared to its average volume of 384,357. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 1.26. Global Medical REIT Inc. has a 1 year low of $7.98 and a 1 year high of $11.59. The firm has a market capitalization of $542.44 million, a price-to-earnings ratio of -405.80, a P/E/G ratio of 1.47 and a beta of 1.21. The firm has a 50 day simple moving average of $8.96 and a two-hundred day simple moving average of $9.21.
Global Medical REIT (NYSE:GMRE - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.21 by ($0.18). Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. The business had revenue of $34.26 million for the quarter, compared to analyst estimates of $34.88 million. During the same period last year, the firm earned $0.23 earnings per share. As a group, equities research analysts anticipate that Global Medical REIT Inc. will post 0.83 earnings per share for the current year.
Global Medical REIT Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 8th. Shareholders of record on Friday, December 20th will be given a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 10.34%. The ex-dividend date is Friday, December 20th. Global Medical REIT's dividend payout ratio (DPR) is presently -4,200.00%.
Global Medical REIT Profile
(
Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Read More
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.